(Q54766777)

3 June 2018

title

A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. (English)

1 reference

3 June 2018

author

Andreas Gille

2

1 reference

3 June 2018

author name string

Rachael Easton

1

1 reference

3 June 2018

Denise D'Andrea

3

1 reference

3 June 2018

Roslyn Davis

4

1 reference

3 June 2018

Samuel D Wright

5

1 reference

3 June 2018

Charles Shear

6

1 reference

3 June 2018

publication date

22 October 2013

1 reference

3 June 2018

The Journal of Clinical Pharmacology

published in

1 reference

3 June 2018

volume

54

1 reference

3 June 2018

issue

3

1 reference

3 June 2018

page(s)

301-310

1 reference

3 June 2018

One-year costs in patients with a history of or at risk for atherothrombosis in the United States.

cites work

1 reference

Coronary plaque disruption.

21 January 2018

1 reference

A prospective natural-history study of coronary atherosclerosis

21 January 2018

1 reference

In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits

21 January 2018

1 reference

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

21 January 2018

1 reference

HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells

21 January 2018

1 reference

HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications

21 January 2018

1 reference

High-density lipoprotein/apolipoprotein A-I infusion therapy

21 January 2018

1 reference

Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?

21 January 2018

1 reference

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

21 January 2018

1 reference

Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.

21 January 2018

1 reference

A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.

21 January 2018

1 reference

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia

21 January 2018

1 reference

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial

21 January 2018

1 reference

ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.

21 January 2018

1 reference

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCPH.194

1 reference

3 June 2018

PubMed ID

24122814

1 reference

3 June 2018